Multi-microarray identifies lower AQP9 expression in adjuvant chemotherapy nonresponders with stage III colorectal cancer

Ruoxu Dou(General Hospital of Guangzhou Military Command), Jianping Wang(Translational Therapeutics (United States)), Lekun Fang(Sun Yat-sen University), Lei Lian(Guizhou University), Shijun Fu(Novartis (China)), Shuyun Tan(Sun Yat-sen University), Gang Jin(Changhai Hospital), Xinjuan Fan(Sun Yat-sen University), Lei Wang(Sun Yat-sen University), Yanhong Deng(Sun Yat-sen University), Lan Huang(81th Hospital of PLA), Huanliang Liu(Sun Yat-sen University)
Cancer Letters
April 22, 2013
10.1016/j.canlet.2013.04.017
Cited by 19

Related Papers

<i>Fusobacterium nucleatum</i>in colorectal carcinoma tissue and patient prognosis
|Gut|2015|1.1k
Early Assessment of Lung Cancer Immunotherapy Response via Circulating Tumor DNA
|Clinical Cancer Research|2018|456
Effect of Fruquintinib vs Placebo on Overall Survival in Patients With Previously Treated Metastatic Colorectal Cancer
|JAMA|2018|410
Neoadjuvant Modified FOLFOX6 With or Without Radiation Versus Fluorouracil Plus Radiation for Locally Advanced Rectal Cancer: Final Results of the Chinese FOWARC Trial
|Journal of Clinical Oncology|2019|410
Modified FOLFOX6 With or Without Radiation Versus Fluorouracil and Leucovorin With Radiation in Neoadjuvant Treatment of Locally Advanced Rectal Cancer: Initial Results of the Chinese FOWARC Multicenter, Open-Label, Randomized Three-Arm Phase III Trial
|Journal of Clinical Oncology|2016|409